Supreme Court Won't Hear Cubicin Patent Appeal

By Kevin Penton (May 31, 2016, 2:17 PM EDT) -- The U.S. Supreme Court on Tuesday declined to review an infringement case over the antibiotic Cubicin in which Cubist Pharmaceuticals Inc. alleged that lower courts erred in nixing the asserted claims of four of the drug's five patents by effectively creating new rules for evaluating a patent's obviousness....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!